UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q
☒ |
Quarterly Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 |
For the quarterly period ended December 31, 2020
☐ |
Transition Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 |
For the transition period from _____ to _____.
Commission File Number: 0-19672
American Superconductor Corporation
(Exact name of registrant as specified in its charter)
Delaware |
04-2959321 |
(State or other jurisdiction of incorporation or organization) |
(I.R.S. Employer Identification No.) |
|
|
114 East Main St. Ayer, Massachusetts |
01432 |
(Address of principal executive offices) |
(Zip Code) |
(978) 842-3000
(Registrant’s telephone number, including area code)
N/A
(Former name, former address and former fiscal year, if changed since last report)
Securities registered pursuant to Section 12(b) of the Act:
Title of each class |
Trading Symbol(s) |
Name of each exchange on which registered |
Common Stock, |
AMSC |
Nasdaq Global Select Market |
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and "emerging growth company" in Rule 12b-2 of the Exchange Act.
Large accelerated filer ☐ |
Accelerated filer ☐ |
Non-accelerated filer ☒ |
Smaller reporting company ☒ |
|
Emerging growth company ☐ |
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒
Shares outstanding of the Registrant’s common stock:
Common Stock, par value $0.01 per share |
|
27,581,625 |
Class |
|
Outstanding as of February 1, 2021 |
AMERICAN SUPERCONDUCTOR CORPORATION
INDEX
|
|
Page No. |
|
||
|
|
|
Item 1. |
3 |
|
|
|
|
Item 2. |
Management’s Discussion and Analysis of Financial Condition and Results of Operations |
21 |
|
|
|
Item 3. |
28 |
|
|
|
|
Item 4. |
28 |
|
|
|
|
|
||
|
|
|
Item 1. |
29 |
|
|
|
|
Item 1A. |
29 |
|
|
|
|
Item 2. |
29 |
|
|
|
|
Item 3. |
29 |
|
|
|
|
Item 4. |
29 |
|
|
|
|
Item 5. |
29 |
|
|
|
|
Item 6. |
30 |
|
|
|
|
|
31 |
AMERICAN SUPERCONDUCTOR CORPORATION
PART I — FINANCIAL INFORMATION
ITEM 1. FINANCIAL STATEMENTS
UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS
(In thousands)
December 31, 2020 |
March 31, 2020 |
|||||||
ASSETS |
||||||||
Current assets: |
||||||||
Cash and cash equivalents |
$ | 67,909 | $ | 24,699 | ||||
Marketable securities |
10,239 | 30,149 | ||||||
Accounts receivable, net |
12,083 | 16,987 | ||||||
Inventory, net |
14,176 | 18,975 | ||||||
Prepaid expenses and other current assets |
4,634 | 2,959 | ||||||
Restricted cash |
629 | 508 | ||||||
Total current assets |
109,670 | 94,277 | ||||||
Marketable securities |
— | 5,046 | ||||||
Property, plant and equipment, net |
9,547 | 8,565 | ||||||
Intangibles, net |
9,964 | 3,550 | ||||||
Right-of-use assets |
3,806 | 3,359 | ||||||
Goodwill |
34,659 | 1,719 | ||||||
Restricted cash |
5,604 | 5,657 | ||||||
Deferred tax assets |
1,386 | 1,551 | ||||||
Other assets |
411 | 385 | ||||||
Total assets |
$ | 175,047 | $ | 124,109 | ||||
LIABILITIES AND STOCKHOLDERS' EQUITY |
||||||||
Current liabilities: |
||||||||
Accounts payable and accrued expenses |
$ | 17,015 | $ | 22,091 | ||||
Lease liability, current portion |
581 | 439 | ||||||
Derivative liabilities |
6,730 | — | ||||||
Deferred revenue, current portion |
15,683 | 18,430 | ||||||
Total current liabilities |
40,009 | 40,960 | ||||||
Deferred revenue, long term portion |
8,695 | 7,712 | ||||||
Lease liability, long term portion |
3,329 | 3,000 | ||||||
Deferred tax liabilities |
70 | 180 | ||||||
Other liabilities |
26 | 38 | ||||||
Total liabilities |
52,129 | 51,890 | ||||||
Commitments and Contingencies (Note 15) |
||||||||
Stockholders' equity: |
||||||||
Common stock |
280 | 229 | ||||||
Additional paid-in capital |
1,120,333 | 1,053,507 | ||||||
Treasury stock |
(3,593 | ) | (2,666 | ) | ||||
Accumulated other comprehensive loss |
(405 | ) | (216 | ) | ||||
Accumulated deficit |
(993,697 | ) | (978,635 | ) | ||||
Total stockholders' equity |
122,918 | 72,219 | ||||||
Total liabilities and stockholders' equity |
$ | 175,047 | $ | 124,109 |
The accompanying notes are an integral part of the unaudited condensed consolidated financial statements.
AMERICAN SUPERCONDUCTOR CORPORATION
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(In thousands, except per share data)
Three Months Ended |
Nine Months Ended |
||||||||||||||||
December 31, |
December 31, |
||||||||||||||||
2020 |
2019 |
2020 |
2019 |
||||||||||||||
Revenues |
$ | 23,632 | $ | 17,915 | $ | 65,961 | $ | 45,697 | |||||||||
Cost of revenues |
19,676 | 16,329 | 51,444 | 38,770 | |||||||||||||
Gross margin |
3,956 | 1,586 | 14,517 | 6,927 | |||||||||||||
Operating expenses: |
|||||||||||||||||
Research and development |
3,029 | 2,049 | 8,248 | 6,920 | |||||||||||||
Selling, general and administrative |
7,085 | 6,071 | 18,609 | 16,726 | |||||||||||||
Amortization of acquisition-related intangibles |
360 | 85 | 601 | 255 | |||||||||||||
Change in fair value of contingent consideration |
2,740 | — | 2,740 | — | |||||||||||||
Total operating expenses |
13,214 | 8,205 | 30,198 | 23,901 | |||||||||||||
Operating loss | (9,258 | ) | (6,619 | ) | (15,681 | ) | (16,974 | ) | |||||||||
Change in fair value of warrants |
— | 556 | — | 4,648 | |||||||||||||
Interest income, net |
53 | 262 | 373 | 1,101 | |||||||||||||
Other (expense)/income, net |
(274 | ) | (932 | ) | (920 | ) | 45 | ||||||||||
Loss before income tax expense (benefit) |
(9,479 | ) | (6,733 | ) | (16,228 | ) | (11,180 | ) | |||||||||
Income tax expense (benefit) |
(1,546 | ) | 112 | (1,166 | ) | 29 | |||||||||||
Net loss |
$ | (7,933 | ) | $ | (6,845 | ) | $ | (15,062 | ) | $ | (11,209 | ) | |||||
Net loss per common share |
|||||||||||||||||
Basic |
$ | (0.31 | ) | $ | (0.32 | ) | $ | (0.65 | ) | $ | (0.54 | ) | |||||
Diluted |
$ | (0.31 | ) | $ | (0.35 | ) | $ | (0.65 | ) | $ | (0.75 | ) | |||||
Weighted average number of common shares outstanding |
|||||||||||||||||
Basic |
25,470 | 21,185 | 23,011 | 20,786 | |||||||||||||
Diluted |
25,470 | 21,203 | 23,011 | 20,894 |
The accompanying notes are an integral part of the unaudited condensed consolidated financial statements.
AMERICAN SUPERCONDUCTOR CORPORATION
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS
(In thousands)
Three Months Ended |
Nine Months Ended |
|||||||||||||||
December 31, |
December 31, |
|||||||||||||||
2020 |
2019 |
2020 |
2019 |
|||||||||||||
Net loss |
$ | (7,933 | ) | $ | (6,845 | ) | $ | (15,062 | ) | $ | (11,209 | ) | ||||
Other comprehensive (loss) income, net of tax: |
||||||||||||||||
Foreign currency translation (loss) gain |
(142 | ) | 609 | (189 | ) | (242 | ) | |||||||||
Total other comprehensive (loss) income, net of tax |
(142 | ) | 609 | (189 | ) | (242 | ) | |||||||||
Comprehensive loss |
$ | (8,075 | ) | $ | (6,236 | ) | $ | (15,251 | ) | $ | (11,451 | ) |
The accompanying notes are an integral part of the unaudited condensed consolidated financial statements.
AMERICAN SUPERCONDUCTOR CORPORATION
UNAUDITED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY
FOR THE THREE AND nine MONTHS ENDED December 31, 2020 AND 2019
(In thousands)
Common Stock |
Additional |
Accumulated Other |
Total |
|||||||||||||||||||||||||
Number of Shares | Par Value | Paid-in Capital | Treasury Stock | Comprehensive Income (Loss) | Accumulated Deficit | Stockholders' Equity | ||||||||||||||||||||||
Balance at March 31, 2020 |
22,902 | $ | 229 | $ | 1,053,507 | $ | (2,666 | ) | $ | (216 | ) | $ | (978,635 | ) | $ | 72,219 | ||||||||||||
Issuance of common stock - restricted shares, net of forfeitures |
493 | 5 | (5 | ) | — | — | — | — | ||||||||||||||||||||
Stock-based compensation expense |
— | — | 909 | — | — | — | 909 | |||||||||||||||||||||
Issuance of stock for 401(k) match |
13 | — | 88 | — | — | — | 88 | |||||||||||||||||||||
Repurchase of treasury stock |
— | — | — | (377 | ) | — | — | (377 | ) | |||||||||||||||||||
Cumulative translation adjustment |
— | — | — | — | (3 | ) | — | (3 | ) | |||||||||||||||||||
Net loss |
— | — | — | — | — | (3,417 | ) | (3,417 | ) | |||||||||||||||||||
Balance at June 30, 2020 |
23,408 | $ | 234 | $ | 1,054,499 | $ | (3,043 | ) | $ | (219 | ) | $ | (982,052 | ) | $ | 69,419 | ||||||||||||
Issuance of common stock - ESPP | 8 | — | 99 | — | — | — | 99 | |||||||||||||||||||||
Issuance of common stock - restricted shares, net of forfeitures | 33 | — | — | — | — | — | — | |||||||||||||||||||||
Stock-based compensation expense | — | — | 849 | — | — | — | 849 | |||||||||||||||||||||
Issuance of stock for 401(k) match | 9 | — | 101 | — | — | — | 101 | |||||||||||||||||||||
Repurchase of treasury stock | — | — | — | (293 | ) | — | — | (293 | ) | |||||||||||||||||||
Cumulative translation adjustment | — | — | — | — | (43 | ) | — | (43 | ) | |||||||||||||||||||
Net loss | — | — | — | — | — | (3,712 | ) | (3,712 | ) | |||||||||||||||||||
Balance at September 30, 2020 | 23,458 | $ | 234 | $ | 1,055,548 | $ | (3,336 | ) | $ | (262 | ) | $ | (985,764 | ) | $ | 66,420 | ||||||||||||
Issuance of common stock - restricted shares, net of forfeitures | (32 | ) | — | — | — | — | — | — | ||||||||||||||||||||
Stock-based compensation expense | — | — | 839 | — | — | — | 839 | |||||||||||||||||||||
Issuance of stock for 401(k) match | 5 | — | 82 | — | — | — | 82 | |||||||||||||||||||||
Issuance of common stock - stock offering | 3,670 | 37 | 51,440 | — | — | — | 51,477 | |||||||||||||||||||||
Issuance of common stock - NEPSI acquisition | 874 | 9 | 12,424 | — | — | — | 12,433 | |||||||||||||||||||||
Repurchase of treasury stock | — | — | — | (257 | ) | — | — | (257 | ) | |||||||||||||||||||
Cumulative translation adjustment | — | — | — | — | (143 | ) | — | (143 | ) | |||||||||||||||||||
Net loss | — | — | — | — | — | (7,933 | ) | (7,933 | ) | |||||||||||||||||||
Balance at December 31, 2020 | 27,975 | $ | 280 | $ | 1,120,333 | $ | (3,593 | ) | $ | (405 | ) | $ | (993,697 | ) | $ | 122,918 |
Common Stock |
Additional |
Accumulated Other |
Total |
|||||||||||||||||||||||||
Number of Shares | Par Value | Paid-in Capital | Treasury Stock | Comprehensive Income (Loss) | Accumulated Deficit | Stockholders' Equity | ||||||||||||||||||||||
Balance at March 31, 2019 |
21,652 | $ | 216 | $ | 1,044,622 | $ | (2,101 | ) | $ | (5 | ) | $ | (961,539 | ) | $ | 81,193 | ||||||||||||
Issuance of common stock - restricted shares |
174 | 2 | (2 | ) | — | — | — | — | ||||||||||||||||||||
Stock-based compensation expense |
— | — | 249 | — | — | — | 249 | |||||||||||||||||||||
Issuance of stock for 401(k) match |
8 | — | 81 | — | — | — | 81 | |||||||||||||||||||||
Issuance of common stock - warrant exercise |
23 | — | 294 | — | — | — | 294 | |||||||||||||||||||||
Repurchase of treasury stock |
— | — | — | (283 | ) | — | — | (283 | ) | |||||||||||||||||||
Cumulative translation adjustment |
— | — | — | — | 418 | — | 418 | |||||||||||||||||||||
Net loss |
— | — | — | — | — | (3,539 | ) | (3,539 | ) | |||||||||||||||||||
Balance at June 30, 2019 |
21,857 | $ | 218 | $ | 1,045,244 | $ | (2,384 | ) | $ | 413 | $ | (965,078 | ) | $ | 78,413 | |||||||||||||
Issuance of common stock - ESPP | 15 | — | 100 | — | — | — | 100 | |||||||||||||||||||||
Issuance of common stock - restricted shares | 10 | — | — | — | — | — | — | |||||||||||||||||||||
Stock-based compensation expense | — | — | 397 | — | — | — | 397 | |||||||||||||||||||||
Issuance of stock for 401(k) match | 12 | — | 92 | — | — | — | 92 | |||||||||||||||||||||
Repurchase of treasury stock | — | — | — | (222 | ) | — | — | (222 | ) | |||||||||||||||||||
Cumulative translation adjustment | — | — | — | — | (1,269 | ) | — | (1,269 | ) | |||||||||||||||||||
Net loss | — | — | — | — | — | (825 | ) | (825 | ) | |||||||||||||||||||
Balance at September 30, 2019 | 21,894 | $ | 218 | $ | 1,045,833 | $ | (2,606 | ) | $ | (856 | ) | $ | (965,903 | ) | $ | 76,686 | ||||||||||||
Issuance of common stock - restricted shares | 167 | 2 | (2 | ) | — | — | — | — | ||||||||||||||||||||
Stock-based compensation expense | — | — | 590 | — | — | — | 590 | |||||||||||||||||||||
Issuance of stock for 401(k) match | 8 | — | 69 | — | — | — | 69 | |||||||||||||||||||||
Issuance of common stock - warrant exercise | 786 | 8 | 6,131 | — | — | — | 6,139 | |||||||||||||||||||||
Repurchase of treasury stock | — | — | — | (60 | ) | — | — | (60 | ) | |||||||||||||||||||
Cumulative translation adjustment | — | — | — | — | 609 | — | 609 | |||||||||||||||||||||
Net loss | — | — | — | — | — | (6,845 | ) | (6,845 | ) | |||||||||||||||||||
Balance at December 31, 2019 | 22,855 | $ | 228 | $ | 1,052,621 | $ | (2,666 | ) | $ | (247 | ) | $ | (972,748 | ) | $ | 77,188 |
The accompanying notes are an integral part of the unaudited condensed consolidated financial statements.
AMERICAN SUPERCONDUCTOR CORPORATION
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(In thousands)
Nine Months Ended December 31, |
||||||||
2020 |
2019 |
|||||||
Cash flows from operating activities: |
||||||||
Net loss |
$ | (15,062 | ) | $ | (11,209 | ) | ||
Adjustments to reconcile net loss to net cash used in operations: |
||||||||
Depreciation and amortization |
3,811 | 3,312 | ||||||
Stock-based compensation expense |
2,597 | 1,236 | ||||||
Provision for excess and obsolete inventory |
1,610 | 491 | ||||||
Deferred income taxes |
(1,828 | ) | (1,069 | ) | ||||
Change in fair value of contingent consideration |
2,740 | — | ||||||
Change in fair value of warrants | — | (4,648 | ) | |||||
Non-cash interest income |
(48 | ) | — | |||||
Other non-cash items |
291 | (22 | ) | |||||
Unrealized foreign exchange loss/(gain) on cash and cash equivalents |
366 | (209 | ) | |||||
Changes in operating asset and liability accounts: |
||||||||
Accounts receivable |
6,376 | (8,661 | ) | |||||
Inventory |
7,419 | (6,968 | ) | |||||
Prepaid expenses and other assets |
6 | (332 | ) | |||||
Accounts payable and accrued expenses |
(7,894 | ) | 2,648 | |||||
Deferred revenue |
(5,255 | ) | 7,652 | |||||
Net cash used in operating activities |
(4,871 | ) | (17,779 | ) | ||||
Cash flows from investing activities: |
||||||||
Purchase of property, plant and equipment |
(1,574 | ) | (2,926 | ) | ||||
Proceeds from the sale of property, plant and equipment |
1 | 3,001 | ||||||
Purchase of marketable securities |
— | (35,000 | ) | |||||
Sale of marketable securities | 25,006 | — | ||||||
Cash paid for acquisition |
(26,000 | ) | — | |||||
Change in other assets |
(6 | ) | 37 | |||||
Net cash used in investing activities |
(2,573 | ) | (34,888 | ) | ||||
Cash flows from financing activities: |
||||||||
Employee taxes paid related to net settlement of equity awards |
(927 | ) | (565 | ) | ||||
Proceeds from exercise of warrants |
— | 6,139 | ||||||
Proceeds from public equity offering, net |
51,477 | — | ||||||
Proceeds from exercise of employee stock options and ESPP |
99 | 100 | ||||||
Net cash provided by financing activities |
50,649 | 5,674 | ||||||
Effect of exchange rate changes on cash |
73 | 30 | ||||||
Net increase/(decrease) in cash, cash equivalents and restricted cash |
43,278 | (46,963 | ) | |||||
Cash, cash equivalents and restricted cash at beginning of period |
30,864 | 78,198 | ||||||
Cash, cash equivalents and restricted cash at end of period |
$ | 74,142 | $ | 31,235 | ||||
Supplemental schedule of cash flow information: |
||||||||
Cash paid for income taxes, net of refunds |
$ | 630 | $ | 3,520 | ||||
Non-cash investing and financing activities |
||||||||
Issuance of common stock in connection with the purchase of Northeast Power Systems, Inc. |
$ | 12,433 | $ | — | ||||
Issuance of common stock to Hercules to settle warrant liability |
— | 294 | ||||||
Issuance of common stock to settle liabilities |
271 | 242 |
The accompanying notes are an integral part of the unaudited condensed consolidated financial statements.
AMERICAN SUPERCONDUCTOR CORPORATION
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
1. Nature of the Business and Operations and Liquidity
Nature of the Business and Operations
American Superconductor Corporation (together with its subsidiaries, “AMSC®” or the “Company”) was founded on April 9, 1987. The Company is a leading system provider of megawatt-scale power resiliency solutions that Orchestrate the Rhythm and Harmony of Power on the Grid™ and that protect and expand the capability of the Navy’s fleet. The Company’s system level products leverage its proprietary “smart materials” and “smart software and controls” to provide enhanced resiliency and improved performance of megawatt-scale power flow.
These unaudited condensed consolidated financial statements of the Company have been prepared on a going concern basis in accordance with United States generally accepted accounting principles (“GAAP”) and the Securities and Exchange Commission’s (“SEC”) instructions to Form 10-Q. The going concern basis of presentation assumes that the Company will continue operations and will be able to realize its assets and discharge its liabilities and commitments in the normal course of business. Certain information and footnote disclosures normally included in the financial statements prepared in accordance with GAAP have been condensed or omitted pursuant to those instructions. The year-end condensed balance sheet data was derived from audited financial statements but does not include all disclosures required by GAAP. The unaudited condensed consolidated financial statements, in the opinion of management, reflect all adjustments (consisting of normal recurring adjustments) necessary for a fair statement of the results for the interim periods ended December 31, 2020 and 2019 and the financial position at December 31, 2020; however, these results are not necessarily indicative of results which may be expected for the full year. The interim condensed consolidated financial statements, and notes thereto, should be read in conjunction with the audited consolidated financial statements for the year ended March 31, 2020, and notes thereto, included in the Company’s Annual Report on Form 10-K for the year ended March 31, 2020 filed with the SEC on June 2, 2020.
Liquidity
The Company has historically experienced recurring operating losses and as of December 31, 2020, the Company had an accumulated deficit of $993.7 million. In addition, the Company has historically experienced recurring negative operating cash flows. At December 31, 2020, the Company had cash, cash equivalents, and marketable securities of $78.1 million. Marketable securities include certificate of deposits with maturities between three and nine months. Cash used in operations for the nine months ended December 31, 2020 was $4.9 million.
In December 2015, the Company entered into a set of strategic agreements valued at approximately $210.0 million with Inox Wind Ltd. (“Inox” or “Inox Wind”), which includes a multi-year supply contract pursuant to which the Company will supply electrical control systems ("ECS") to Inox and a license agreement allowing Inox to manufacture a limited number of ECS. After Inox purchases the specified number of ECS required under the terms of the supply contract, Inox agreed that the Company will continue as Inox’s preferred supplier and Inox will be required to purchase from the Company a majority of its ECS requirements for an additional three-year period. Pursuant to these strategic agreements, Inox must forecast future purchase orders of sets of ECS which become firm orders three months prior to shipment, and Inox must post letters of credit before the Company will ship such orders. Inox had been delinquent on its obligation to post letters of credit for sets of ECS that Inox forecasted to purchase under the terms of the supply contract. On May 29, 2020, the Company sent written notice to Inox notifying Inox of its default under the supply contract due to Inox’s failure to post letters of credit in the amount of €6.0 million for the payment of ECS that Inox is obligated to purchase under the terms of the supply contract. If Inox failed to post letters of credit in the amount of €6.0 million in accordance with the terms of the supply contract within the ninety day cure period after receipt of the default notice, then the Company could have terminated the supply contract by providing written notice of such termination to Inox. On September 2, 2020, Inox delivered approved letters of credit in the amount of €1.3 million for the payment of a portion of the ECS that Inox was obligated to purchase under the terms of the supply contract. On September 11, 2020, the Company notified Inox that due to (i) the Company’s business relationship with Inox, and (ii) Inox’s delivery of approved letters of credit in the amount of €1.3 million as described above, the Company gave Inox until October 5, 2020 to regain compliance with the terms of the supply contract by providing approved letters of credit in the amount of €4.7 million for payment of the remaining ECS that Inox currently was obligated to purchase under the terms of the supply contract. On October 1, 2020, Inox delivered approved letters of credit for payment of the remaining ECS that Inox was obligated to purchase under the terms of the supply contract and cured the default set forth in the May 29, 2020 default notice.
On October 1, 2020 (the "Acquisition Date"), the Company entered into a Stock Purchase Agreement (the “Stock Purchase Agreement”) with the selling stockholders named therein. Pursuant to the terms of the Stock Purchase Agreement and concurrently with entering into such agreement, the Company acquired all of the issued and outstanding (i) shares of capital stock of Northeast Power Systems, Inc., a New York corporation (“NEPSI”), and (ii) membership interests of Northeast Power Realty, LLC, a New York limited liability company, which holds the real property that serves as NEPSI’s headquarters (the "Acquisition"). NEPSI is a U.S.-based global provider of medium-voltage metal-enclosed power capacitor banks and harmonic filter banks for use on electric power systems. NEPSI is now a wholly-owned subsidiary of the Company and is operated by its Grid business unit. The purchase price was $26.0 million in cash and 873,657 restricted shares of common stock of the Company. As part of the transaction, the selling stockholders may receive up to an additional 1,000,000 shares of common stock of the Company upon the achievement of certain specified revenue objectives in the future.
On October 22, 2020, the Company entered into an underwriting agreement with Oppenheimer & Co. Inc., as representative of the several underwriters named therein, relating to the issuance and sale (the “Offering”) of 3,670,000 shares of the Company’s common stock at a public offering price of $15.00 per share. The net proceeds to the Company from the Offering were approximately $51.5 million, after deducting underwriting discounts and commissions and offering expenses payable by the Company. The Offering closed on October 26, 2020. In addition, the Company had granted the underwriters a 30-day option to purchase up to an additional 550,500 shares of common stock at the public offering price which was not exercised.
In March 2020, the World Health Organization declared the disease caused by the novel coronavirus, COVID-19, to be a pandemic. COVID-19 has spread throughout the globe, including in the Commonwealth of Massachusetts where the Company’s headquarters are located, and in other areas where the Company has business operations. In response to the outbreak, the Company has followed the guidelines of the U.S. Centers for Disease Control and Prevention and applicable state government authorities to protect the health and safety of the Company’s employees, families, suppliers, customers and communities. While these existing measures and, COVID-19 generally, have not materially disrupted the Company’s business to date, any future actions necessitated by the COVID-19 pandemic may result in disruption to the Company’s business.
While the COVID-19 pandemic continues to rapidly evolve, the Company continues to assess the impact of the COVID-19 pandemic to best mitigate risk and continue the operations of the Company’s business. The extent to which the outbreak impacts the Company’s business, liquidity, results of operations and financial condition will depend on future developments, which are highly uncertain and cannot be predicted with confidence, including new information that may emerge concerning the severity of the COVID-19 pandemic and the actions to contain it or treat its impact, among others. If the Company, its customers or suppliers experience prolonged shutdowns or other business disruptions, the Company’s business, liquidity, results of operations and financial condition are likely to be materially adversely affected, and the Company’s ability to access the capital markets may be limited.
The Company believes that based on the information presented above and its quarterly management assessment, it has sufficient liquidity to fund its operations and capital expenditures for the next twelve months following the issuance of the financial statements for the nine months ended December 31, 2020. The Company’s liquidity is highly dependent on its ability to increase revenues, including its ability to collect revenues under its agreements with Inox, its ability to control its operating costs, and its ability to raise additional capital, if necessary. The impact of the COVID-19 pandemic on the global financing markets may reduce the Company's ability to raise additional capital, if necessary, which could negatively impact the Company's liquidity. There can be no assurance that the Company will be able to continue to raise additional capital, on favorable terms or at all, from other sources or execute on any other means of improving liquidity described above.
2. NEPSI Acquisition
As described in Note 1, Nature of the Business and Operations and Liquidity, on the Acquisition Date, the Company acquired all of the issued and outstanding shares of capital stock of NEPSI and membership interests of Northeast Power Realty, LLC, a New York limited liability company, which holds the real property that serves as NEPSI’s headquarters. NEPSI is a U.S.-based global provider of medium-voltage metal-enclosed power capacitor banks and harmonic filter banks for use on electric power systems. Prior to the Acquisition, the Company had purchased $0.4 million of products from NEPSI in fiscal year 2019 for which NEPSI was paid and had recorded revenue.
Pursuant to the Stock Purchase Agreement, the Company acquired all of the issued and outstanding shares of NEPSI, and membership interest in the realty entity, for which the Company paid $26.0 million in cash and issued 873,657 restricted shares of the Company’s common stock. Additionally, the Company may issue to the selling stockholders up to an additional 1,000,000 shares of common stock upon NEPSI’s achievement of specified revenue objectives during varying periods of up to four years following closing of the Acquisition. This contingent consideration is recorded as a derivative liability based on a Monte Carlo simulation to determine fair value at the time of issuance. NEPSI is now a wholly-owned subsidiary of the Company and is operated and reported as a component of its Grid business unit.
The Acquisition completed by the Company during the nine months ended December 31, 2020 has been accounted for under the purchase method of accounting in accordance with ASC 805, Business Combinations. The Company allocated the purchase price to the assets acquired and liabilities assumed at their estimated fair values as of the date of acquisition. The excess of the purchase price paid by the Company over the estimated fair value of net assets acquired has been recorded as goodwill. As NEPSI was previously a private company, the adoption of Accounting Standards Codification ("ASC 606") was completed as part of the Acquisition. See Note 3 "Revenue Recognition" for further details. There were no leases acquired and the Acquisition had no impact to the Company's reporting under ASC 842.
The total purchase price of approximately $42.4 million includes the fair value of shares of the Company’s common stock issued at closing, cash paid, and contingent consideration as follows (in millions):
Cash payment |
$ | 26.0 | ||
Issuance of 873,657 shares of Company’s common stock |
12.4 | |||
Contingent consideration |
4.0 | |||
Total consideration |
42.4 |
At the Acquisition Date, in addition to the $26.0 million cash, the Company valued the Company’s common stock, using $14.23 per share, which was the closing price on the day that the Company acquired NEPSI and $4.0 million of contingent consideration for the earnout liability valued as of the Acquisition Date. Acquisition costs of $0.3 million were recorded in selling, general and administrative ("SG&A") costs for the three and nine months ended December 31, 2020.
The fair value of the contingent consideration was determined using a Monte Carlo model and is accounted for as a derivative liability which is revalued at the fair value determined at each subsequent balance sheet date until the contingencies are resolved and the shares to be issued are determined, with the change in fair value recorded in the current period operating loss or (income). See Note 13, "Warrants and Derivative Liabilities" for further details and a summary of key assumptions used to determine fair value in each period.
The following table summarizes the allocation of the purchase price based on the estimated fair values of the assets acquired and liabilities assumed and related deferred income taxes in connection with the Acquisition (in millions):
Net working capital (excluding inventory and deferred revenue) |
$ | 0.1 | ||
Inventory |
4.2 | |||
Property, plant and equipment |
2.3 | |||
Deferred revenue |
(2.7 | ) | ||
Deferred tax liability |
(1.7 | ) | ||
Net tangible assets/(liabilities) |
2.2 | |||
Backlog |
0.6 | |||
Trade names and trademarks |
0.6 | |||
Customer relationships |
6.1 | |||
Net identifiable intangible assets/(liabilities) |
7.3 | |||
Goodwill |
32.9 | |||
Total purchase consideration |
$ | 42.4 |
Inventory includes a $1.0 million adjustment to step up the inventory balance to fair value consistent with the purchase price allocation. The fair value was determined based on the estimated selling price of the inventory, less the remaining manufacturing and selling cost and a normal profit margin on those manufacturing and selling efforts. The $1.0 million step up adjustment increased cost of revenue in the three and nine months periods ended December 31, 2020 as the inventory was sold. This increase is not reflected in the pro forma condensed combined statements of operations because it does not have a continuing impact beyond the first year.
Backlog of $0.6 million was evaluated using the multi period excess earnings method under the income approach. The contracts with customers do not provide for any guarantees to source all future requirements from the Company. The amortization method being utilized is economic consumption estimated over a two year period with the expense being allocated to cost of revenues.
Customer relationships of $6.1 million relates to customers currently under contract and was determined based on a multi period excess earnings method under the income approach. The method of amortization being utilized is the economic consumption over 7 years with the expense being allocated to SG&A.
Trade names and trademarks of $0.6 million were reviewed, using the assumption that the Company would continue to utilize the NEPSI trade name indefinitely. The relief from royalty method was utilized using an 8% royalty rate on revenues with a 13% discount rate over 8 years.
Goodwill represents the value associated with the acquired workforce and expected synergies related to the business combination of the two companies. Goodwill resulting from the Acquisition was assigned to the Company’s Grid segment. Goodwill recognized in the Acquisition is not deductible for tax purposes. This purchase price allocation is preliminary and has not been finalized as the analysis on the assets and liabilities acquired, primarily the tax related liability may require further adjustments to our purchase accounting that could result in a measurement period adjustment that would impact our reported net assets and goodwill as of October 1, 2020. Material changes, if any, to the preliminary allocation summarized above will be reported once the related uncertainties are resolved, but no later than October 1, 2021. The $1.7 million of deferred tax liability is primarily related to inventory step up and intangibles.
Three Months Ended December 31, |
Nine Months Ended December 31, |
|||||||||||||||
2020 |
2019 |
2020 |
2019 |
|||||||||||||
Revenues |
$ | 23,632 | $ | 22,412 | $ | 78,298 | $ | 66,135 | ||||||||
Operating loss |
(8,769 | ) | (6,988 | ) | (15,016 | ) | (15,469 | ) | ||||||||
Net loss |
$ | (9,169 | ) | $ | (7,117 | ) | $ | (15,775 | ) | $ | (7,879 | ) | ||||
Net loss per common share |
||||||||||||||||
Basic |
$ | (0.36 | ) | $ | (0.32 | ) | $ | (0.67 | ) | $ | (0.36 | ) | ||||
Diluted |
$ | (0.36 | ) | $ | (0.35 | ) | $ | (0.67 | ) | $ | (0.57 | ) | ||||
Shares - basic |
25,470 | 22,059 | 23,594 | 21,660 | ||||||||||||
Shares - diluted | 25,470 | 22,077 | 23,594 | 21,768 |
3. Revenue Recognition
The Company’s revenues in its Grid segment are derived primarily through enabling the transmission and distribution of power, providing planning services that allow it to identify power grid needs and risks, and developing ship protection systems for the U.S. Navy. The Company’s revenues in its Wind segment are derived primarily through supplying advanced power electronics and control systems, licensing its highly engineered wind turbine designs, and providing extensive customer support services to wind turbine manufacturers. The Company records revenue based on a five-step model in accordance with ASC 606, Revenue from Contracts with Customers. For its customer contracts, the Company identifies the performance obligations, determines the transaction price, allocates the contract transaction price to the performance obligations, and recognizes the revenue when (or as) control of goods or services is transferred to the customer. In the three and nine months ended December 31, 2020, 78% and 79% of revenue, respectively, was recognized at the point in time when control transferred to the customer, with the remainder being recognized over time. In the three and nine months ended December 31, 2019, 57% and 69%, respectively, of revenue was recognized at the point in time when control transferred to the customer, with the remainder being recognized over time.
Following the Acquisition of NEPSI, the Company evaluated all open NEPSI contracts at the date of the Acquisition against a five-step model in accordance with ASC 606 as NEPSI, as a private company, had deferred adopting ASC606 prior to the Acquisition, as permitted. The Company identified two NEPSI revenue streams which are (1) the sale of its major components which falls under the equipment and systems product line and (2) the sale of spare parts, which falls under the service product line. Further details on each of these product lines can be found below. The Company does not expect a material impact to its consolidated statements of operations on an ongoing basis resulting from the adoption of the ASC 606 standard for the NEPSI business, and NEPSI revenue streams will follow the existing policies noted below.
In the Company's equipment and system product line, each contract with a customer summarizes each product sold to a customer, which typically represents distinct performance obligations. A contract's transaction price is allocated to each distinct performance obligation using the respective standalone selling price which is determined primarily using the cost-plus expected margin approach and recognized as revenue when, or as, the performance obligation is satisfied. The majority of the Company’s product sales transfer control to the customer in line with the contracted delivery terms and revenue is recorded at the point in time when title and risk transfer to the customer, which is primarily upon delivery, as the Company has determined that this is the point in time that control transfers to the customer.
The Company's equipment and system product line includes certain contracts which do not meet the requirements of an exchange transaction and therefore do not fall within the scope of ASC 606. As these non-exchange transaction contracts are considered grant revenue and do not fall within any specific accounting literature, the Company follows guidance within ASC 606 by analogy to recognize grant revenue over time. In the three and nine months ended December 31, 2020, the Company recorded $1.1 million and $1.8 million in grant revenue, respectively, which is included in the Company’s Grid segment revenue. In the three and nine months ended December 31, 2019, the Company recorded $3.9 million and $5.3 million in grant revenue, respectively, which is included in the Company’s Grid segment revenue.
In the Company's service and technology development product line, there are several different types of transactions and each begins with a contract with a customer that summarizes each product sold to a customer, which typically represent distinct performance obligations. The technology development transactions are primarily for activities that have no alternative use and for which a profit can be expected throughout the life of the contract. In these cases, the revenue is recognized over time, but in the instances where the profit cannot be assured throughout the entire contract, the revenue is recognized at a point in time. Each contract's transaction price is allocated to each distinct performance obligation using the respective standalone selling price which is determined primarily using the cost-plus expected margin approach. The ongoing service transactions are for service contracts that provide benefit to the customer simultaneously as the Company performs its obligations, and therefore this revenue is recognized ratably over time throughout the effective period of these contracts. The transaction prices on these contracts are allocated based on an adjusted market approach which is re-assessed annually for reasonableness. The field service transactions include contracts for delivery of goods and completion of services made at the customer's requests, which are not deemed satisfied until the work has been completed and/or the requested goods have been delivered, so all of this revenue is recognized at the point in time when the control changes, and at allocated prices based on the adjusted market approach driven by standard price lists. The royalty transactions are related to certain contract terms on transactions in the Company's equipment and systems product line based on activity as specified in the contracts. The transaction prices of these agreements are calculated based on an adjusted market approach as specified in the contract. The Company reports royalty revenue for usage-based royalties when the sales have occurred. In circumstances when collectability is not assured and a contract does not exist under ASC 606, revenue is deferred until a non-refundable payment has been received for substantially all the amount that is due and there are no further remaining performance obligations.
The Company's service contracts can include a purchase order from a customer for specific goods in which each item is a distinct performance obligation satisfied at a point in time at which control of the goods is transferred to the customer. This transfer occurs based on the contracted delivery terms or when the requested service work has been completed. The transaction price for these goods is allocated based on the adjusted market approach considering similar transactions under similar circumstances. Service contracts are also derived from ongoing maintenance contracts and extended service-type warranty contracts. In these transactions, the Company is contracted to provide an ongoing service over a specified period of time. As the customer is consuming the benefits as the service is being provided, the revenue is recognized over time ratably.
The Company’s policy is not to accept volume discounts, product returns, or rebates and allowances within its contracts. In the event a contract was approved with any of these terms, it would be evaluated for variable consideration, estimated and recorded as a reduction of revenue in the same period the related product revenue was recorded.
The Company provides assurance-type warranties on all product sales for a term of typically one to three years, and extended service-type warranties at the customer's option for an additional term ranging up to four additional years. The Company accrues for the estimated warranty costs for assurance warranties at the time of sale based on historical warranty experience plus any known or expected changes in warranty exposure. For all extended service-type warranties, the Company recognizes the revenue ratably over time during the effective period of the services.
The Company records revenue net of sales tax, value added tax, excise tax and other taxes collected concurrent with revenue-producing activities. The Company has elected to recognize the cost for freight and shipping when control over the products sold passes to customers and revenue is recognized. The Company has elected to recognize incremental costs of obtaining a contract as expense when incurred except in contracts where the amortization period would exceed twelve months; in such cases the long-term amount will be assessed for materiality. The Company has elected not to adjust the promised amount of consideration for the effects of a significant financing component if the period of financing is twelve months or less.
The Company’s contracts with customers do not typically include extended payment terms and may include milestone billing over the life of the contract. Payment terms vary by contract type and type of customer and generally range from 30 to 60 days from delivery.
The following tables disaggregate the Company’s revenue by product line and by shipment destination:
Three Months Ended December 31, 2020 |
Nine Months Ended December 31, 2020 |
|||||||||||||||
Product Line: |
Grid |
Wind |
Grid |
Wind |
||||||||||||
Equipment and systems | $ | 15,930 | $ | 6,153 | $ | 47,729 | $ | 12,828 | ||||||||
Services and technology development | 1,156 | 393 | 3,420 | 1,984 | ||||||||||||
Total |
$ | 17,086 | $ | 6,546 | $ | 51,149 | $ | 14,812 | ||||||||
Region: |
||||||||||||||||
Americas | $ | 13,394 | $ | 14 | $ | 39,626 | $ | 56 | ||||||||
Asia Pacific | 351 | 6,461 | 6,736 | 14,463 | ||||||||||||
EMEA | 3,341 | 71 | 4,787 | 293 | ||||||||||||
Total |
$ | 17,086 | $ | 6,546 | $ | 51,149 | $ | 14,812 |
Three Months Ended December 31, 2019 |
Nine Months Ended December 31, 2019 |
|||||||||||||||
Product Line: |
Grid |
Wind |
Grid |
Wind |
||||||||||||
Equipment and systems |
$ | 14,040 | $ | 2,160 | $ | 32,438 | $ | 7,742 | ||||||||
Services and technology development |
1,192 | 523 | 4,139 | 1,379 | ||||||||||||
Total |
$ | 15,232 | $ | 2,683 | $ | 36,577 | $ | 9,120 | ||||||||
Region: |
||||||||||||||||
Americas |
$ | 10,164 | $ | 2 | $ | 28,663 | $ | 49 | ||||||||
Asia Pacific |
330 | 2,647 | 2,550 | 8,968 | ||||||||||||
EMEA |
4,738 | 34 | 5,364 | 104 | ||||||||||||
Total |
$ | 15,232 | $ | 2,683 | $ | 36,577 | $ | 9,120 |
As of December 31, 2020, and 2019, the Company’s contract assets and liabilities primarily relate to the timing differences between cash received from a customer in connection with contractual rights to invoicing and the timing of revenue recognition following completion of performance obligations. The Company's accounts receivable balance is made up entirely of customer contract related balances. Changes in the Company’s contract assets, which are included in “Unbilled accounts receivable” and “Deferred program costs” (see Note 8, “Accounts Receivable” and Note 9, “Inventory” for a reconciliation to the condensed consolidated balance sheets) and contract liabilities, which are included in the current portion and long term portion of "Deferred revenue" in the Company’s condensed consolidated balance sheets, are as follows:
Unbilled Accounts Receivable | Deferred Program Costs | Contract Liabilities | ||||||||||
Beginning balance as of March 31, 2020 |
$ | 5,711 | $ | 1,631 | $ | 26,142 | ||||||
Increases for costs incurred to fulfill performance obligations |
— | 6,635 | — | |||||||||
Increase for balances acquired | 101 | — | 2,700 | |||||||||
Increase (decrease) due to customer billings |
(8,255 | ) | — | 42,785 | ||||||||
Decrease due to cost recognition on completed performance obligations |
— | (6,969 | ) | — | ||||||||
Increase (decrease) due to recognition of revenue based on transfer of control of performance obligations |
6,644 | — | (48,274 | ) | ||||||||
Other changes and FX impact |
— | 33 | 1,025 | |||||||||
Ending balance as of December 31, 2020 |
$ | 4,201 | $ | 1,330 | $ | 24,378 |
Unbilled Accounts Receivable | Deferred Program Costs | Contract Liabilities | ||||||||||
Beginning balance as of March 31, 2019 |
$ | 2,213 | $ | 318 | $ | 15,519 | ||||||
Increases for costs incurred to fulfill performance obligations |
— | 3,001 | — | |||||||||
Increase (decrease) due to customer billings |
(7,417 | ) | — | 36,461 | ||||||||
Decrease due to cost recognition on completed performance obligations |
— | (2,221 | ) | — | ||||||||
Increase (decrease) due to recognition of revenue based on transfer of control of performance obligations |
9,820 | — | (28,768 | ) | ||||||||
Other changes and FX impact |
(3 | ) | (1 | ) | (69 | ) | ||||||
Ending balance as of December 31, 2019 |
$ | 4,613 | $ | 1,097 | $ | 23,143 |
The Company’s remaining performance obligations represent the unrecognized revenue value of the Company’s contractual commitments. The Company’s performance obligations may vary significantly each reporting period based on the timing of major new contractual commitments. As of December 31, 2020, the Company had outstanding performance obligations on existing contracts under ASC 606 to be recognized in the next twelve months of approximately $51.1 million. There are also approximately $7.2 million of outstanding performance obligations to be recognized over a period of thirteen to sixty months. The remaining performance obligations are subject to customer actions and therefore the timing of revenue recognition cannot be reasonably estimated. The twelve-month performance obligations include anticipated shipments to Inox based on the twelve-month rolling forecast provided by Inox on the multi-year supply contract. The quantities specified in any forecast provided by Inox related to the multi-year supply contract are firm and irrevocable for the first three months of a twelve-month rolling forecast. The timing of the performance obligations beyond the twelve-month forecast provided by Inox are not determinable and therefore are not included in the total remaining performance obligations.
The following table sets forth customers who represented 10% or more of the Company’s total revenues for the three and nine months ended December 31, 2020 and 2019:
Three Months Ended |
Nine Months Ended |
||||||||||||||||
Reportable |
December 31, |
December 31, |
|||||||||||||||
Segment |
2020 |
2019 |
2020 |
2019 |
|||||||||||||
Inox Wind Limited |
Wind |
24 | % | <10% | 12 | % | 11 | % | |||||||||
Department of Homeland Security |
Grid |
<10% | 22 | % | <10% | 12 | % | ||||||||||
Vestas |
Grid |
<10% | 25 | % | <10% | 10 | % | ||||||||||
EPC Services |
Grid |
14 | % | <10% | 17 | % | <10% |
4. Stock-Based Compensation
The Company accounts for its stock-based compensation at fair value. The following table summarizes stock-based compensation expense by financial statement line item for the three and nine months ended December 31, 2020 and 2019 (in thousands):
Three Months Ended December 31, |
Nine Months Ended December 31, |
|||||||||||||||
2020 |
2019 |
2020 |
2019 |
|||||||||||||
Cost of revenues | $ | (23 | ) | $ | 21 | $ | 35 | $ | 45 | |||||||
Research and development | 179 | 117 | 470 | 219 | ||||||||||||
Selling, general and administrative | 683 | 452 | 2,092 | 971 | ||||||||||||
Total |
$ | 839 | $ | 590 | $ | 2,597 | $ | 1,236 |
The Company issued 27,341 shares of immediately vested common stock and 697,167 shares of restricted stock awards during the nine months ended December 31, 2020 and issued 13,174 shares of immediately vested common stock and 366,000 shares of restricted stock awards during the nine months ended December 31, 2019. These restricted stock awards generally vest over 2-3 years. Awards for restricted stock include both time-based and performance-based awards. For options and restricted stock awards that vest upon the passage of time, expense is being recorded over the vesting period. Performance-based awards are expensed over the requisite service period based on probability of achievement.
The estimated fair value of the Company’s stock-based awards, less expected annual forfeitures, is amortized over the awards’ service period. The total unrecognized compensation cost for unvested outstanding stock options was less than $0.1 million at December 31, 2020. This expense will be recognized over a weighted average expense period of approximately 0.4 years. The total unrecognized compensation cost for unvested outstanding restricted stock was $5.2 million at December 31, 2020. This expense will be recognized over a weighted-average expense period of approximately 1.9 years.
The Company did not grant any stock options during the nine months ended December 31, 2020. The Company granted 5,939 stock options during the nine months ended December 31, 2019. The stock options granted during the nine months ended December 31, 2019 will vest over 2 years. The weighted average assumptions used in the Black Scholes valuation model for stock options granted during the nine months ended December 31, 2019 are as follows:
Three Months Ended December 31, |
Nine Months Ended December 31, |
|||||||||||||||
2020 |
2019 |
2020 |
2019 |
|||||||||||||
Expected volatility |
N/A | N/A | N/A | 66.5 | % | |||||||||||
Risk-free interest rate |
N/A | N/A | N/A | 1.8 | % | |||||||||||
Expected life (years) |
N/A | N/A | N/A | 5.91 | ||||||||||||
Dividend yield |
N/A | N/A | N/A |
None |
5. Computation of Net Loss per Common Share
Basic net loss per share (“EPS”) is computed by dividing net loss by the weighted-average number of common shares outstanding for the period. Where applicable, diluted EPS is computed by dividing the net loss by the weighted-average number of common shares and dilutive common equivalent shares outstanding during the period, calculated using the treasury stock method. Common equivalent shares include the effect of restricted stock, exercise of stock options and warrants and contingently issuable shares. Stock options and warrants that are out-of-the-money with exercise prices greater than the average market price of the underlying common shares and shares of performance based restricted stock where the contingency was not met are excluded from the computation of diluted EPS as the effect of their inclusion would be anti-dilutive. For the three and nine months ended December 31, 2020, 1.1 million shares were not included in the calculation of diluted EPS. Of these, 1.0 million relate to shares tied to the derivative liability for which the contingency has not yet been met, and 0.1 million relate to outstanding stock options as they were considered anti-dilutive. For the three and nine months ended December 31, 2019, 0.1 million shares related to outstanding stock options were not included in the calculation of diluted EPS as they were considered anti-dilutive.
The following table reconciles the numerators and denominators of the earnings per share calculation for the three and nine months ended December 31, 2020 and 2019 (in thousands, except per share data):
Three Months Ended December 31, |
Nine Months Ended December 31, |
|||||||||||||||
2020 |
2019 |
2020 |
2019 |
|||||||||||||
Numerator: |
||||||||||||||||
Net loss |
$ | (7,933 | ) | $ | (6,845 | ) | $ | (15,062 | ) | $ | (11,209 | ) | ||||
Less: decrease in fair value of warrants, net of income tax |
— | (556 | ) | — | (4,648 | ) | ||||||||||
Plus: change in fair value due to exercise of warrants |
— | — | — | 83 | ||||||||||||
Net loss - diluted | $ | (7,933 | ) | $ | (7,401 | ) | $ | (15,062 | ) | $ | (15,774 | ) | ||||
Denominator: |
||||||||||||||||
Weighted-average shares of common stock outstanding | 26,532 | 22,110 | 24,143 | 21,729 | ||||||||||||
Weighted-average shares subject to repurchase | (1,062 | ) | (925 | ) | (1,132 | ) | (943 | ) | ||||||||
Shares used in per-share calculation ― basic | 25,470 | 21,185 | 23,011 | 20,786 | ||||||||||||
Common stock warrants | — | 18 | — | 108 | ||||||||||||
Shares used in per-share calculation ― diluted | 25,470 | 21,203 | 23,011 | 20,894 | ||||||||||||
Net loss per share ― basic | $ | (0.31 | ) | $ | (0.32 | ) | $ | (0.65 | ) | $ | (0.54 | ) | ||||
Net loss per share ― diluted | $ | (0.31 | ) | $ | (0.35 | ) | $ | (0.65 | ) | $ | (0.75 | ) |
For the three and nine months ended December 31, 2019, the diluted net loss per common share amounts under the treasury stock method were calculated based on the dilutive effect of the total number of shares of common stock related to the warrants issued to Hudson Bay Capital (the “Hudson Warrants”) for 818,181 shares with an exercise price of $7.81. For the three and nine month periods ended December 31, 2019, the average stock price was $8.19 and $9.29 respectively through November 13, 2019 when the Hudson Warrant was partially exercised for 786,000 shares, providing 37,962 and 130,345 dilutive shares respectively. The increase of $0.6 million and the decrease of $4.6 million in the fair value of the warrant liability, respectively, is included in the net loss available to common shareholders for the diluted net loss per common share amount when the impact is dilutive.
6. Goodwill and Other Intangibles
Goodwill
The guidance under ASC 805-30 provides for the recognition of goodwill on the Acquisition Date measured as the excess of the aggregate consideration transferred over the net of the Acquisition Date amounts of net assets acquired and liabilities assumed. The Company's goodwill balance relates to the Acquisition of NEPSI in the current year and ITC in fiscal 2017 and is reported in the Grid business segment. The fair market value of the contingent consideration included in the total consideration transferred was determined using the Monte Carlo model, and all other consideration transferred was calculated using its observable fair market value. The tangible net assets acquired fair market value was based on observable market fair value. The acquired intangible asset fair value was determined using discounted cash flows under an excess in earnings model or relief in royalty method where appropriate.
Goodwill represents the difference between the purchase price and the fair value of the identifiable tangible and intangible net assets when accounted for using the purchase method of accounting. Goodwill is not amortized but reviewed for impairment. Goodwill is reviewed annually and whenever events or changes in circumstances indicate that the carrying value of the goodwill might not be recoverable.
The following table provides a roll forward of the changes in our Grid business segment goodwill balance:
Goodwill |
||||
March 31, 2020 |
$ | 1,719 | ||
NEPSI Acquisition |
32,940 | |||
Less impairment loss |
- | |||
December 31, 2020 |
$ | 34,659 |
The Company did not identify any triggering events in the three and nine months ended December 31, 2020, that would require interim impairment testing of goodwill.
Other Intangibles
Intangible assets at December 31, 2020 and March 31, 2020 consisted of the following (in thousands):
December 31, 2020 |
March 31, 2020 |
|||||||||||||||||||||||||||
Gross Amount |
Accumulated Amortization |
Net Book Value |
Gross Amount |
Accumulated Amortization |
Net Book Value |
Estimated Useful Life |
||||||||||||||||||||||
Backlog |
$ | 600 | $ | (285 | ) | $ | 315 | $ | — | $ | — | $ | — | 2 | ||||||||||||||
Trade name | 600 | — | 600 | — | — | — | Indefinite | |||||||||||||||||||||
Customer relationships |
6,100 | (239 | ) | 5,861 | — | — | — | 7 | ||||||||||||||||||||
Core technology and know-how |
5,970 | (2,782 | ) | 3,188 | 5,970 | (2,420 | ) | 3,550 | 5-10 | |||||||||||||||||||
Intangible assets |
$ | 13,270 | $ | (3,306 | ) | $ | 9,964 | $ | 5,970 | $ | (2,420 | ) | $ | 3,550 |
The Company recorded intangible amortization expense related to customer relationship and core technology and know-how of $0.4 million and $0.6 million in the three and nine months ended December 31, 2020, respectively, and $0.1 and $0.3 million for the three and nine months ended December 31, 2019, respectively. Additionally, in each of the three and nine months ended December 31, 2020 the Company recorded $0.3 million related to intangible amortization related to backlog that is reported in cost of revenues.
Expected future amortization expense related to intangible assets is as follows (in thousands):
Years ended March 31, |
Total |
|||
2021 | 826 | |||
2022 | 2,115 | |||
2023 | 1,808 | |||
2024 | 1,393 | |||
2025 | 1,077 | |||
Thereafter | 2,145 | |||
Total |
$ | 9,364 |
The Company's intangible assets relate entirely to the Grid business segment operations in the United States.
7. Fair Value Measurements
A valuation hierarchy for disclosure of the inputs to valuation used to measure fair value has been established. This hierarchy prioritizes the inputs into three broad levels as follows:
Level 1 |
- |
Inputs are unadjusted quoted prices in active markets for identical assets or liabilities that the Company has the ability to access at the measurement date. |
|
|
|
Level 2 |
- |
Inputs include quoted prices for similar assets and liabilities in active markets, quoted prices for identical or similar assets or liabilities in markets that are not active, inputs other than quoted prices that are observable for the asset or liability, and inputs that are derived principally from or corroborated by observable market data by correlation or other means (market corroborated inputs). |
|
|
|
Level 3 |
- |
Unobservable inputs that reflect the Company’s assumptions that market participants would use in pricing the asset or liability. The Company develops these inputs based on the best information available, including its own data. |
The Company provides a gross presentation of activity within Level 3 measurement roll-forward and details of transfers in and out of Level 1 and 2 measurements. A change in the hierarchy of an investment from its current level is reflected in the period during which the pricing methodology of such investment changes. Disclosure of the transfer of securities from Level 1 to Level 2 or Level 3 is made in the event that the related security is significant to total cash and investments. The Company did not have any transfers of assets and liabilities from Level 1, Level 2 or Level 3 of the fair value measurement hierarchy during the nine months ended December 31, 2020.
A financial asset’s or liability’s classification within the hierarchy is determined based on the lowest level input that is significant to the fair value measurement.
Valuation Techniques
Cash Equivalents
Cash equivalents consist of highly liquid instruments with maturities of three months or less that are regarded as high quality, low risk investments, are measured using such inputs as quoted prices and are classified within Level 1 of the valuation hierarchy. Cash equivalents consist principally of certificates of deposits and money market accounts.
Marketable Securities
Marketable securities consist of certificates of deposit that are measured using such inputs as quoted prices and are classified within Level 1 of the valuation hierarchy. The Company determines the appropriate classification of its marketable securities at the time of purchase and re-evaluates such classification as of each balance sheet date. All marketable securities are considered available for sale and are carried at fair value. Changes in fair value are recorded to other income (expense), net. The Company recognized no change in the three months ended December 31, 2020 and $0.2 million in unrealized losses on marketable securities, which is recorded in other income (expense), net, for the nine months ended December 31, 2020 and less than a $0.1 million gain which was recognized during the nine months ended December 31, 2020 upon the sale of one of the certificates of deposit. The Company did not recognize any gains or losses on marketable securities in the three and nine months ended December 31, 2019. The Company periodically reviews the realizability of each short and long term marketable security when impairment indicators exist with respect to the security. If other than temporary impairment of value of the security exists, the carrying value of the security is written down to its estimated fair value.
Contingent Consideration
Contingent consideration relates to the earnout payment set forth in the Stock Purchase Agreement that provides that the selling stockholders may receive up to an additional 1,000,000 shares of common stock of the Company upon the achievement of certain specified revenue objectives over varying periods of up to four years following the Acquisition Date. See Note 13, "Warrants and Derivative Liabilities" and Note 2, “NEPSI Acquisition” for further discussion. The Company relied on a Monte Carlo method to determine the fair value of the contingent consideration on the Acquisition Date and will continue to revalue the fair value of the contingent consideration using the same method at each subsequent balance sheet date until the contingencies are resolved and the shares to be issued are determined, with the change in fair value recorded in the current period operating loss.
Warrants
The Company issued the Hudson Warrants in conjunction with an equity offering to Hudson Bay Capital in November 2014 and issued warrants to purchase 58,823 shares of the Company's common stock in conjunction a Loan and Security Agreement with Hercules Technology Growth Capital, Inc. (“Hercules Warrants”). The Hercules Warrants were exercised on April 8, 2019. The Hudson Warrants were partially exercised on November 13, 2019 and the remaining unexercised warrants expired on November 13, 2019. As of December 31, 2020, the Company has no remaining outstanding warrants.
The Company historically relied on various assumptions in a lattice model to determine the fair value of warrants. The Company had valued the warrants within Level 3 of the valuation hierarchy. See Note 13, “Warrants and Derivative Liabilities,” for a discussion of the warrants and the valuation assumptions used.
The following table provides the assets and liabilities carried at fair value on a recurring basis, measured as of December 31, 2020 and March 31, 2020 (in thousands):
Total Carrying Value |
Quoted Prices in Active Markets (Level 1) |
Significant Other Observable Inputs (Level 2) |
Significant Unobservable Inputs (Level 3) |
|||||||||||||
December 31, 2020: |
||||||||||||||||
Assets: |
||||||||||||||||
Cash equivalents |
$ | 56,101 | $ | 56,101 | $ | — | $ | — | ||||||||
Marketable securities |
$ | 10,239 | $ | 10,239 | $ | — | $ | — | ||||||||
Derivative liabilities: | ||||||||||||||||
Contingent consideration | $ | 6,730 | $ | — | $ | — | $ | 6,730 |
Total Carrying Value | Quoted Prices in Active Markets (Level 1) | Significant Other Observable Inputs (Level 2) | Significant Unobservable Inputs (Level 3) | |||||||||||||
March 31, 2020: |
||||||||||||||||
Assets: |
||||||||||||||||
Cash equivalents |
$ | 19,394 | $ | 19,394 | $ | — | $ | — | ||||||||
Marketable securities |
$ | 35,195 | $ | 35,195 | $ | — | $ | — |
The table below reflects the activity for the Company’s derivative liability measured at fair value on a recurring basis (in thousands):
Acquisition Contingent Consideration |
||||
April 1, 2020 |
$ | - | ||
Issuance of contingent consideration |
3,990 | |||
Mark to market adjustment |
2,740 | |||
Balance at December 31, 2020 |
$ | 6,730 |
8. Accounts Receivable
Accounts receivable at December 31, 2020 and March 31, 2020 consisted of the following (in thousands):
December 31, 2020 |
March 31, 2020 |
|||||||
Accounts receivable (billed) | $ | 7,897 | $ | 11,276 | ||||
Accounts receivable (unbilled) | 4,201 | 5,711 | ||||||
Less: Allowance for doubtful accounts | (15 | ) | — | |||||
Accounts receivable, net |
$ | 12,083 | $ | 16,987 |
The Company recorded allowance for doubtful accounts of less than $0.1 million for the three and nine months ended December 31, 2020 and no allowance for the three and nine months ended December 31, 2019. The allowances are based on evaluation of customer accounts that are past due.
9. Inventory
Inventory, net of reserves, at December 31, 2020 and March 31, 2020 consisted of the following (in thousands):
December 31, 2020 |
March 31, 2020 |
|||||||
Raw materials | $ | 7,651 | $ | 10,739 | ||||
Work-in-process | 3,497 | 1,345 | ||||||
Finished goods | 1,698 | 5,260 | ||||||
Deferred program costs | 1,330 | 1,631 | ||||||
Net inventory |
$ | 14,176 | $ | 18,975 |
The Company recorded inventory write-downs of $0.4 million and $0.3 million for the three months ended December 31, 2020 and 2019, respectively. The Company recorded inventory write-downs of $1.6 million and $0.5 million for the nine months ended December 31, 2020 and 2019, respectively. These write-downs were based on the Company's evaluation of its inventory on hand for excess quantities and obsolescence.
Deferred program costs as of December 31, 2020 and March 31, 2020 primarily represent costs incurred on programs where the Company needs to complete performance obligations before the related revenue and costs will be recognized.
10. Property, Plant and Equipment
The cost and accumulated depreciation of property, plant and equipment at December 31, 2020 and March 31, 2020 are as follows (in thousands):
December 31, 2020 |
March 31, 2020 |
|||||||
Construction in progress - equipment | $ | 111 | $ | 3,130 | ||||
Land | 270 | — | ||||||
Building | 1,630 | — | ||||||
Equipment and software | 41,743 | 41,737 | ||||||
Furniture and fixtures | 1,310 | 1,302 | ||||||
Leasehold improvements | 6,306 | 2,477 | ||||||
Property, plant and equipment, gross | 51,370 | 48,646 | ||||||
Less accumulated depreciation | (41,823 | ) | (40,081 | ) | ||||
Property, plant and equipment, net |
$ | 9,547 | $ | 8,565 |
Depreciation expense was $1.2 million and $1.0 million for the three months ended December 31, 2020 and 2019, respectively. Depreciation expense was $2.9 million and $3.1 million for the nine months ended December 31, 2020 and 2019, respectively. The decrease in construction in progress primarily relates to the completion of capital investments in the Company's HTS equipment and leasehold improvements in the Company's leased facilities in Westminster and Ayer, Massachusetts. The increase in land and building relates to the property added as part of the NEPSI Acquisition.
11. Accounts Payable and Accrued Expenses
Accounts payable and accrued expenses at December 31, 2020 and March 31, 2020 consisted of the following (in thousands):
December 31, 2020 |
March 31, 2020 |
|||||||
Accounts payable | $ | 3,664 | $ | 10,045 | ||||
Accrued inventories in-transit | 1,131 | 763 | ||||||
Accrued other miscellaneous expenses | 2,397 | 1,986 | ||||||
Advanced deposits | 1,417 | 666 | ||||||
Accrued compensation | 5,751 | 5,683 | ||||||
Income taxes payable | 635 | 933 | ||||||
Accrued product warranty | 2,020 | 2,015 | ||||||
Total |
$ | 17,015 | $ | 22,091 |
The Company generally provides a one to three year warranty on its products, commencing upon delivery or installation where applicable. A provision is recorded upon revenue recognition to cost of revenues for estimated warranty expense based on historical experience.
Product warranty activity was as follows (in thousands):
Three Months Ended December 31, |
Nine Months Ended December 31, |
|||||||||||||||
2020 |
2019 |
2020 |
2019 |
|||||||||||||
Balance at beginning of period | $ | 2,109 | $ | 1,641 | $ | 2,015 | $ | 1,545 | ||||||||
Acquired warranty obligations | 147 | — | 147 | — | ||||||||||||
Change in accruals for warranties during the period | 124 | 93 | 507 | 247 | ||||||||||||
Settlements during the period | (360 | ) | (28 | ) | (649 | ) | (86 | ) | ||||||||
Balance at end of period |
$ | 2,020 | $ | 1,706 | $ | 2,020 | $ | 1,706 |
12. Income Taxes
The Company recorded an income tax benefit of $1.5 million and $1.2 million in the three and nine month periods ended December 31, 2020, respectively. The Company recorded income tax expense of $0.1 million in the three months ended December 31, 2019, and less than $0.1 million in the nine months ended December 31, 2019.
As a result of a difference in book and tax basis related to the intangible assets acquired in the Acquisition (see Note 2, "NEPSI Acquisition"), the Company recorded a deferred tax liability of $1.7 million. As a result, the Company was able to benefit from additional deferred tax assets and therefore released a corresponding valuation allowance of $1.7 million during the three and nine months ended December 31, 2020. The purchase price allocation is preliminary and has not been finalized as the analysis on the assets and liabilities acquired, primarily the tax related liability, may require further adjustments to the Company's purchase accounting that could result in measurement period adjustments that would impact the Company's reported net assets and goodwill as of October 1, 2020. Material changes, if any, to the preliminary allocation summarized in Note 2, "NEPSI Acquisition" will be reported once the related uncertainties are resolved, but no later than October 1, 2021. Goodwill recognized in the Acquisition is not deductible for tax purposes.
Accounting for income taxes requires a two-step approach to recognizing and measuring uncertain tax positions. The first step is to evaluate the tax position for recognition by determining if, based on the technical merits, it is more likely than not the position will be sustained upon audit, including resolution of related appeals or litigation processes, if any. The second step is to measure the tax benefit as the largest amount that is more than 50% likely to be realized upon ultimate settlement. The Company re-evaluates these uncertain tax positions on a quarterly basis. The evaluation is based on factors including, but not limited to, changes in facts or circumstances, changes in tax law, effectively settled issues under audit and new audit activity. Any changes in these factors could result in the recognition of a tax benefit or an additional charge to the tax provision. The Company did not identify any uncertain tax positions in the nine months ended December 31, 2020 and did not have any gross unrecognized tax benefits as of March 31, 2020.
13. Warrants and Derivative Liabilities
Contingent Consideration
The Company evaluated the Acquisition earnout payment set forth in the Stock Purchase Agreement (see Note 2, "NEPSI Acquisition" for further details), which may require settlement in the Company's common stock, and determined the contingent consideration qualified for liability classification and derivative treatment under ASC 815, Derivatives and Hedging. As a result, for each period, the fair value of the contingent consideration will be remeasured and the resulting gain or loss will be recognized in operating expenses until the share amount is fixed.
Following is a summary of the key assumptions used in a Monte Carlo simulation to calculate the fair value of the contingent consideration related to the Acquisition:
December 31, |
October 1, |
|||||||
Fiscal Year 2020 |
2020 |
2020 |
||||||
Revenue risk premium |
6.90 | % | 7.10 | % | ||||
Revenue volatility |
30 | % | 30 | % | ||||
Stock Price |
$ | 23.42 | $ | 14.23 | ||||
Payment delay (days) |
80 | — | ||||||
Fair value |
$6.7 million |
$4.0 million |
The Company recorded a net loss of $2.7 million resulting from the increase in the fair value of the contingent consideration in both the three and nine months ended December 31, 2020.
Warrants
The Company accounted for its warrants as liabilities due to certain adjustment provisions within the instruments, which required that they be recorded at fair value. The warrants were subject to revaluation at each balance sheet date and any change in fair value was recorded as a change in fair value of warrants until the earlier of its expiration or its exercise at which time the warrant liability was reclassified to equity. The Company calculated the fair value of the warrants utilizing an integrated lattice model. See Note 7, "Fair Value Measurements", for further discussion. As of December 31, 2020, the Company had no remaining outstanding warrants.
Hercules Warrants
On December 19, 2014, the Company entered into a second amendment to the Loan and Security Agreement with Hercules (the "Hercules Second Amendment"). In conjunction with the Hercules Second Amendment, the Company issued the Hercules Warrant which replaced the First Warrant and the Second Warrant. The Hercules Warrant was exercisable at any time after its issuance at an exercise price of $7.85 per share, subject to certain price-based and other anti-dilution adjustments, including the equity offering in May 2017, the acquisition of Infinia Technology Corporation ("ITC") with common stock in September 2017 and sales of common stock under the ATM entered into in January 2017. This warrant had a fair value of $0.4 million as of March 31, 2019. On April 8, 2019, Hercules notified the Company of its intent to exercise this warrant on a cashless basis. Hercules received 22,821 shares of the Company's common stock on April 17, 2019. As a result of this exercise the Company recorded a net gain of $0.1 million to change in fair value of warrants, resulting from the decrease in the fair value of the Hercules Warrant during the nine months ended December 31, 2019.
November 2014 Warrant
On November 13, 2014, the Company completed an offering of 909,090 units of the Company’s common stock with Hudson Bay Capital. Each unit consisted of one share of the Company’s common stock and 0.9 of a warrant to purchase one share of common stock, or a warrant to purchase in the aggregate 818,181 shares. The Hudson Warrants were exercisable at any time, at an exercise price equal to $7.81 per share, subject to certain price-based and other anti-dilution adjustments including those noted above. On November 13, 2019, Hudson partially exercised the Hudson Warrants for 786,000 restricted shares of Company common stock at $7.81 per share. The remaining 32,181 warrants expired on November 13, 2019. The Company recorded net gains of $0.5 million and $4.6 million to change in fair value of warrants, resulting from the decrease in the fair value of the Hudson Warrants during the three and nine months ended December 31, 2019, respectively.
14. Leases
On April 1, 2019, the Company adopted ASU 2016-02, Leases (Topic 842) ("ASC 842"), using the modified retrospective approach. The Company elected the package of practical expedients available in the standard and as a result, did not reassess the lease classification of existing contracts or leases or the initial direct costs associated with existing leases. The Company did not elect the hindsight practical expedient and evaluated lease terms for existing leases. The Company has also elected the practical expedient to not separate lease components and non-lease components and will account for the leases as a single lease component for all classes of leases.
All significant lease arrangements are recognized at lease commencement. Operating lease right–of-use assets and lease liabilities are recognized at commencement. The operating lease right-of-use asset includes any lease payments related to initial direct cost and prepayments and excludes any lease incentives. Lease expense is recognized on a straight-line basis over the lease term. The Company enters into a variety of operating lease agreements through the normal course of its business, but primarily real estate leases to support its operations. The real estate lease agreements generally provide for fixed minimum rental payments and the payment of real estate taxes and insurance. Many of these real estate leases have one or more renewal options that allow the Company, at its discretion, to renew the lease for varying periods up to five years or to terminate the lease. Only renewal options or termination rights that the Company believed were likely to be exercised were included in the lease calculations.
The Company also enters into leases for vehicles, IT equipment and service agreements, and other leases related to its manufacturing operations that are also included in the right-of-use assets and lease liability accounts if they are for a term of longer than twelve months. However, many of these leases are either short-term in nature or immaterial. The Company has made the policy election to exclude short-term leases from the balance sheet.
The discount rate was calculated using an incremental borrowing rate based on an assessment prepared by the Company through the use of Company credit ratings, consideration of its lease populations potential risk to its total capital structure, and a market rate for a collateralized loan for its risk profile, calculated by a third party. The Company elected to apply the discount rate using the remaining lease term at the date of adoption.
The Company did not identify any leases that are classified as financing leases.
Supplemental balance sheet information related to leases at December 31, 2020 and March 31, 2020 are as follows:
December 31, 2020 |
March 31, 2020 |
|||||||
Operating Leases: |
||||||||
Right-of-use assets |
$ | 3,806 | $ | 3,359 | ||||
Total right-of-use assets | 3,806 | 3,359 | ||||||
Lease liabilities - ST |
$ | 581 | $ | 439 | ||||
Lease liabilities - LT |
3,329 | 3,000 | ||||||
Total operating lease liabilities | 3,910 | 3,439 | ||||||
Weighted-average remaining lease term | 6.04 | 6.91 | ||||||
Weighted-average discount rate | 6.76 | % | 7.08 | % |
The costs related to the Company's leases for the three and nine months ended December 31, 2020 and 2019 are as follows:
Three Months Ended |
Nine Months Ended |
|||||||